FY2028 EPS Estimates for TriMas Increased by Zacks Research

TriMas Corporation (NASDAQ:TRS) – Investment analysts at Zacks Research lifted their FY2028 earnings per share estimates for TriMas in a research report issued on Tuesday, May 26th. Zacks Research analyst Team now expects that the industrial products company will post earnings per share of $2.20 for the year, up from their prior estimate of $2.09. Zacks Research currently has a “Hold” rating on the stock. The consensus estimate for TriMas’ current full-year earnings is $1.67 per share.

TriMas (NASDAQ:TRS) last issued its quarterly earnings results on Thursday, April 30th. The industrial products company reported $0.24 EPS for the quarter, missing analysts’ consensus estimates of $0.48 by ($0.24). The business had revenue of $168.28 million for the quarter, compared to analyst estimates of $158.24 million. TriMas had a net margin of 93.79% and a return on equity of 8.38%. TriMas’s revenue for the quarter was up 10.3% on a year-over-year basis. During the same period last year, the business posted $0.46 earnings per share. TriMas has set its FY 2026 guidance at 1.500-1.70 EPS.

TRS has been the topic of a number of other reports. KeyCorp reissued an “overweight” rating and set a $38.00 price target on shares of TriMas in a report on Thursday, February 26th. BWS Financial reissued a “buy” rating and set a $45.00 price target on shares of TriMas in a report on Monday, March 2nd. Finally, Weiss Ratings raised TriMas from a “buy (b-)” rating to a “buy (b)” rating in a report on Friday, May 22nd. Three equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $41.50.

TriMas Price Performance

Shares of TRS opened at $41.16 on Thursday. The firm has a market capitalization of $1.47 billion, a price-to-earnings ratio of 1.71 and a beta of 0.58. The company has a debt-to-equity ratio of 0.27, a quick ratio of 4.50 and a current ratio of 4.85. TriMas has a one year low of $25.58 and a one year high of $43.72. The stock’s fifty day moving average is $37.85 and its 200-day moving average is $35.97.

TriMas Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, May 14th. Investors of record on Thursday, May 7th were issued a dividend of $0.04 per share. This represents a $0.16 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date of this dividend was Thursday, May 7th. TriMas’s payout ratio is presently 0.66%.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of TRS. Capital International Investors acquired a new position in TriMas during the third quarter worth about $111,673,000. Jefferies Financial Group Inc. purchased a new position in TriMas in the 4th quarter worth about $55,036,000. Permian Investment Partners LP acquired a new stake in TriMas during the 4th quarter worth about $29,192,000. SG Americas Securities LLC lifted its stake in TriMas by 688.2% during the first quarter. SG Americas Securities LLC now owns 667,091 shares of the industrial products company’s stock valued at $23,975,000 after buying an additional 582,452 shares in the last quarter. Finally, Alberta Investment Management Corp purchased a new stake in TriMas during the fourth quarter valued at about $16,605,000. 99.42% of the stock is owned by institutional investors and hedge funds.

About TriMas

TriMas Corporation is a diversified industrial company headquartered in Bloomfield Hills, Michigan. Established in 1980, TriMas has built a global reputation for designing and manufacturing specialized products that serve a wide array of end markets. The company operates through multiple segments, each focused on high-demand niches where engineered solutions and rigorous quality standards are essential.

The Packaging segment supplies closures, dispensing systems and related components for the personal care, household chemicals, food and beverage, and pharmaceutical markets.